Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm

Clinical trial NCT01259557 · COMPLETED

Trial details

NCT number: NCT01259557
Sponsor: Medy-Tox
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Essential Blepharospasm

Start date: 2010-08-01
Primary completion: 2011-05-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.